Adrenalin Vials Injection
Product Images NDC 70385-2024

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Adrenalin Vials (NDC 70385-2024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sina Health Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

FDA Label Image

1 mL Vial Label (Image 2)

This text contains information about the medication Adrenalin (epinephrine injection, USP) which is available in a 1 mg/mL concentration in a 1 mL single-dose vial. It is indicated for intravenous infusion, intramuscular, and subcutaneous use but should be diluted before intravenous infusion and should not be used for ophthalmic purposes. The user should discard any unused portion. For more information, users should refer to the full prescribing information. The medication is manufactured for Endo USA and has an expiry date of RO03/2024.*

FDA Label Image

30 mL Vial Label (Image 3)

FDA Label Image

1 mL Carton (Image 4)

FDA Label Image

30 mL Carton (Image 5)

This is a description of a medication called Adrenalin (epinephrine injection, USP) which comes in a 30 mg/30 mL (1 mg/mL) strength. It is intended for intravenous infusion, intramuscular, and subcutaneous use. This medication should be discarded 30 days after the initial use. It is emphasized that it is NOT for Ophthalmic Use. The text also mentions specific storage instructions, formulation, and dosage details for this medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.